US HCR42 | 2021-2022 | 117th Congress

Status

Spectrum: Slight Partisan Bill (Republican 11-7)
Status: Introduced on July 21 2021 - 25% progression, died in committee
Action: 2021-07-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Sponsors


History

DateChamberAction
2021-07-22HouseReferred to the Subcommittee on Health.
2021-07-21HouseReferred to the House Committee on Energy and Commerce.
2021-07-21HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback